![Christine Roth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Roth
Director/Board Member at
FARON PHARMACEUTICALS OY
Net worth: 25 325 $ as of 31/08/2026
Profile
Christine Roth currently works at Faron Pharmaceuticals Oy, as Independent Non-Executive Director from 2023.
Ms. Roth also formerly worked at Bayer AG, as Executive VP-Oncology Strategic Business from 2022 to 2024.
Ms. Roth received her undergraduate degree from the University of North Carolina at Chapel Hill.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 48,022 ( 0.02% ) | 25 325 $ | 31/08/2026 |
Christine Roth active positions
| Companies | Position | Start |
|---|---|---|
| FARON PHARMACEUTICALS OY | Director/Board Member | 22/09/2023 |
Former positions of Christine Roth
| Companies | Position | End |
|---|---|---|
| BAYER AG | Corporate Officer/Principal | 01/01/2024 |
Training of Christine Roth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Faron Pharmaceuticals Oy
 Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
University of North Carolina at Chapel Hill
 University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Christine Roth
